Navigation Links
Flexpoint Announces Progress on the Medical Bed and Related Technologies
Date:4/18/2013

DRAPER, Utah, April 18, 2013 /PRNewswire/ -- Flexpoint Sensor Systems, Inc. (OTCQB: FLXT) today announced that it is nearing completion of a potential settlement in the legal case involving a series of products featuring  technologies that use Bend Sensor® technology.

The agreement reinforces Flexpoint's intellectual property rights and provides the company with revenue from all sales of related products moving forward plus provides an opportunity for increased sales as lines are expanded into other products.  The medical bed industry represents an approximately $2 billion industry annually for beds alone.

Clark Mower , President of Flexpoint stated, "We are excited that we are back working together and are working to complete a settlement on the major issues involved. The settlement not only resolves the legal issues, but provides the basis for an ongoing relationship moving forward. The settlement will allow the company to move forward in an industry that has significant potential for the use of our innovative Bend Sensor® technology.  For some years, it has been apparent that the medical bed and related applications have strong interest in the growing medical and home care markets.  We have received numerous inquiries on application of our technology, even during the pendency of the litigation.  These products represent years of innovative development, and we are excited to see them progress and realize their significant market potential."  

About Flexpoint:
Flexpoint Sensor Systems (OTCBB: FLXT) is an innovative technology firm specializing in developing products that feature the Company's patented Bend Sensor® and related technology.  The Bend Sensor® is a groundbreaking sensing solution that is revolutionizing applications in the automotive, safety, medical and industrial industries. The Bend Sensor's single-layer, thin film construction cuts costs and mechanical bulk while introducing a range of functions and stylistic design possibilities that have never before been available in sensing technology. Flexpoint's technology and expertise have been recognized by the world's elite business and academic innovators for over 17 years. The company is setting a new standard for sensing solutions in the "smart" age of technology. 

Forward-Looking Statements
This press release contains certain forward-looking statements.  Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Contact Information:
Flexpoint Sensor Systems
Clark Mower , President
801-568-5111

Brokers and Analysts:
Chesapeake Group
410-825-3930


'/>"/>
SOURCE Flexpoint Sensor Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
2. Flexpoint to Develop New Sensor Type
3. Flexpoint Completes Certification for Pressure Relief Device
4. Sales of Flexpoint Sensors Increases Substantially in January
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):